Delpor is a clinical-stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic diseases. The Company is focusing on CNS conditions including Schizophrenia, Opioid Use Disorder, Spasticity, Parkinson’s, Alzheimer’s, and MS.